Clasp Therapeutics logo

Clasp Therapeutics Funding & Investors

Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type.

clasptx.com/home

Total Amount Raised: $150,000,000

Clasp Therapeutics Funding Rounds

  • Series A

    $150,000,000

    Series A Investors

    Catalio Capital Management
    Novo Holdings
    Third Rock Ventures
    BrightEdge Fund
    Blackbird Ventures
    Vivo Capital
    Cure Ventures
    Pictet Alternative Advisors
    Alexandria Venture Investments
Funding info provided by Diffbot.